AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.28X leverage
Akums Drugs & Pharmaceuticals live price: ₹500.6. It opened at ₹480 vs previous close ₹480; intraday high/low: ₹503/₹480. The 50 & 200 DMA stand at ₹462.12/₹491.62.
Akums Drugs & Pharmaceuticals Performance
- Low
- ₹480
- High
- ₹503
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹480
- Previous Close₹480
- Volume265,575
- 50 DMA₹462.12
- 100 DMA₹460.51
- 200 DMA₹491.62
Investment Returns
- Over 1 Month + 7.15%
- Over 3 Month + 18.74%
- Over 6 Month + 8.3%
- Over 1 Year -0.6%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 24.8
- PEG Ratio
- 0.2
- Market Cap Cr
- 7,879
- P/B Ratio
- 2.4
- Average True Range
- 17.02
- EPS
- 20.62
- Dividend Yield
- 0
- MACD Signal
- 8.78
- RSI
- 63.43
- MFI
- 52.67
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹500.60
+
21
(4.38%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹475.38
- 50 Day
- ₹462.12
- 100 Day
- ₹460.51
- 200 Day
- ₹491.62
Resistance and Support
494.4
- R3 532.60
- R2 517.80
- R1 509.20
- S1 485.80
- S2 471.00
- S3 462.40
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹500 As on 11 March, 2026 | 06:00
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7879.1 Cr As on 11 March, 2026 | 06:00
The P/E ratio of Akums Drugs & Pharmaceuticals is 24.8 As on 11 March, 2026 | 06:00
The PB ratio of Akums Drugs & Pharmaceuticals is 2.4 As on 11 March, 2026 | 06:00
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.